503072-63-7 Usage
Structure
Contains a benzyl group, a tert-butyl group, and a pyrazolidine ring
Usage
Intermediate in the synthesis of pharmaceuticals and other organic compounds
Diuretic
Promotes increased urine production to remove excess water and salt from the body
Vasodilator
Helps widen blood vessels, improving blood flow and reducing blood pressure
Anti-inflammatory
May help reduce inflammation in the body
Anti-cancer
Potentially useful in the development of cancer treatments
Significance
Valuable component in medicinal chemistry and drug development due to its unique structure and properties
Check Digit Verification of cas no
The CAS Registry Mumber 503072-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,0,7 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 503072-63:
(8*5)+(7*0)+(6*3)+(5*0)+(4*7)+(3*2)+(2*6)+(1*3)=107
107 % 10 = 7
So 503072-63-7 is a valid CAS Registry Number.
503072-63-7Relevant academic research and scientific papers
The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones
Laufersweiler, Matthew J.,Brugel, Todd A.,Clark, Michael P.,Golebiowski, Adam,Bookland, Roger G.,Laughlin, Steven K.,Sabat, Mark P.,Townes, Jennifer A.,VanRens, John C.,De, Biswanath,Hsieh, Lily C.,Heitmeyer, Sandra A.,Juergens, Karen,Brown, Kimberly K.,Mekel, Marlene J.,Walter, Richard L.,Janusz, Michael J.
, p. 4267 - 4272 (2007/10/03)
Novel substituted [5,5]-bicyclic pyrzazolones are presented as inhibitors of tumor necrosis factor-α (TNF-α) production. Many of these compounds show low nanomolar activity against lipopolysaccaride (LPS)-induced TNF-α production in THP-1 cells. This clas
